GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, FDPS, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NR1H4 |
12.3378 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, ESR1, F3, FABP3, FABP4, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NR1H4, PPARA, PTAFR, SLC1A1, THRA, THRB, TNKS, TNKS2, XDH |
10.8971 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, FABP3, FABP4, FDPS, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NR1H4, PPARA |
8.81183 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DAO, DRD1, FDPS, GBA2, HMGCR, NR1H4, PTAFR, TYR |
8.33933 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NR1H4 |
8.33933 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.78278 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FDPS, FUT7, GBA2, HMGCR, NR1H4, PPARA, PTAFR, TYR, XDH |
7.0891 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.05819 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, FABP3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, NR1H4, PPARA, PTAFR, TYR |
7.00486 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, FDPS, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.73294 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.68784 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.22341 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, FABP3, FABP4, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, NR1H4, PPARA, PTAFR, TYR |
5.98547 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.96794 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, NR1H4, PTAFR, TYR |
5.64651 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.51863 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, THRA, THRB |
5.38853 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.31 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.19033 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5, PTAFR |
5.01916 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.89046 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.89046 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, GRM1, GRM3, GRM5, GRM8 |
4.89046 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, GRM1, GRM3, GRM5, GRM8 |
4.87933 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, GRM5, HSD11B2, NR1H4, PPARA, PTAFR |
4.87039 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, THRA, THRB |
4.83598 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, DAO, FDPS, HMGCR, PTAFR, TYR |
4.80389 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, THRA, THRB |
4.71083 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, THRA, THRB |
4.56257 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, PPARA, PTAFR |
4.48429 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.47567 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.47533 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, GRM1, GRM3, GRM5, GRM8 |
4.46557 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, FABP3, FABP4, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, NR1H4, PPARA, PTAFR, TYR |
4.44938 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, FDPS, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.44795 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FDPS, HMGCR |
4.39508 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.39188 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, GRM1, GRM3, GRM5, GRM8 |
4.36887 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 |
4.35498 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, BCL2, CA2, CA7, CDK6, DRD1, HMGCR, NR1H4, TNKS, TNKS2 |
4.21442 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, THRA, THRB |
4.16708 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, ADRA2C, GRM5, PTPN1 |
4.16708 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, HSD11B2, PTAFR, TYR |
4.1262 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, GRM1, HMGCR, NR1H4, PTPN1, TNKS, TNKS2, XDH |
4.1262 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, GRM1, HMGCR, NR1H4, PTPN1, TNKS, TNKS2, XDH |
4.10406 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, GRIK5, GRM1, GRM5, HMGCR, NR1H4, PPARA, PTAFR, PTPN1, THRA, THRB, TNKS, TNKS2, XDH |
4.0965 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, GRIK5, GRM1, GRM5, HMGCR, NR1H4, PPARA, PTAFR, PTPN1, SLC1A1, THRA, THRB, TNKS, TNKS2, XDH |
3.90741 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, F3, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, NR1H4, PTPN1, THRA, TNKS, TNKS2, XDH |
3.84459 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, NR1H4, PPARA, SLC1A1 |
3.8323 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, BCL2, CDC25B, DRD1, ESRRB, FABP3, FABP4, GRM1, GRM3, GRM5, GRM8, HMGCR, NR1H4, PPARA, PTAFR, PTPN1, XDH |
3.8145 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, BCL2, CDC25B, DRD1, ESRRB, FABP3, FABP4, GRM1, GRM3, GRM5, GRM8, HMGCR, NR1H4, PPARA, PTAFR, PTPN1, XDH |
3.7726 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, F3, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, NR1H4, PTPN1, THRA, TNKS, TNKS2, XDH |
3.76579 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, NR1H4 |
3.70269 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALPL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRB, F3, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD11B2, HSD17B2, PPARA, PTAFR, THRA, THRB, TNKS2, TYR |
3.68211 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, BCL2, CDC25B, DRD1, ESRRB, FABP3, GRM1, GRM5, HMGCR, NR1H4, PTAFR, PTPN1, XDH |
3.68211 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, BCL2, CDC25B, DRD1, ESRRB, FABP3, GRM1, GRM5, HMGCR, NR1H4, PTAFR, PTPN1, XDH |
3.68211 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.67448 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FDPS |
3.63146 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FDPS, FUT7, GBA2, HMGCR, PPARA |
3.62654 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FDPS, HMGCR, NR1H4, PPARA, THRA |
3.45395 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, PPARA, THRA, TYR |
3.33425 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ADRA2C, BCL2, CDC25B, CSNK2A1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, GRM1, GRM5, HMGCR, NR1H4, PPARA, PTAFR, PTPN1, THRA, THRB, TNKS, TNKS2, XDH |
3.33398 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, HMGCR, PTAFR |
3.31463 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, HMGCR, PTAFR |
3.31463 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, NR1H4, PPARA, PTAFR, PTPN1, THRA, THRB, TNKS, TNKS2 |
3.28355 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, PTAFR, SLC1A1, THRA, THRB |
3.28181 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CYP1B1, DRD1, GRM1, GRM5, GRM8, HMGCR, HSD11B2, PTAFR, THRA, THRB, TYR |
3.22754 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, HMGCR, PTAFR |
3.17981 |
[BP] GO:0061097 |
None
|
ADORA1, ADRA2A, ADRA2C, GRM5, PTPN1 |
3.17981 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, HMGCR, PTAFR |
3.17404 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.17404 |
[BP] GO:0051930 |
None
|
ADORA1, ADRA2C, GRM1, PTAFR |
3.15594 |
[BP] GO:0051931 |
None
|
ADORA1, ADRA2C, GRM1, PTAFR |
3.15594 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
3.11923 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ADRA2C, BCL2, CDC25B, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, GRM1, GRM5, HMGCR, NR1H4, PPARA, PTAFR, PTPN1, THRA, THRB, TNKS, TNKS2, XDH |
3.10532 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DAO, DRD1, TYR |
3.09951 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1 |
3.09762 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ADRA2C, BCL2, CDC25B, CSNK2A1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, GRM1, GRM5, HMGCR, NR1H4, PPARA, PTAFR, PTPN1, THRA, THRB, TNKS, TNKS2, XDH |
3.0804 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ADRA2C, BCL2, CDC25B, CSNK2A1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, GRM1, GRM5, HMGCR, NR1H4, PPARA, PTAFR, PTPN1, THRA, THRB, TNKS, TNKS2, XDH |
3.0804 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, GRIK5, GRM5, HMGCR, NR1H4, PPARA, PTAFR, PTPN1, THRA |
3.03783 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, HMGCR, TNKS, TNKS2 |
3.01711 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, PTAFR |
3.01541 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, NR1H4, PPARA, SLC1A1 |
2.99918 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NR1H4, PPARA, PTAFR, PTPN1, THRA, THRB, TNKS, TNKS2, TYR, XDH |
2.99204 |
[BP] GO:0045741 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.96754 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.86976 |
[BP] GO:0046165 |
None
|
AKR1B1, CYP3A4, FDPS, HMGCR, PTAFR |
2.86976 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, HMGCR, PTAFR |
2.86976 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, BCL2, CA2, CYP1A1, DRD1, GRM1, HMGCR, HSD11B2, PPARA, PTAFR, THRA, TYR |
2.84302 |
[BP] GO:0008050 |
None
|
THRA, THRB |
2.81352 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.81352 |
[BP] GO:0022414 |
reproductive process
|
ADRA2C, AKR1B1, ALPL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, HSD17B2, PTAFR, THRA, THRB |
2.7823 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, NR1H4 |
2.77027 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, GRIK5, GRM5, NR1H4, PTAFR |
2.65698 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA2C, DRD1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.5351 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, PPARA, THRA |
2.52213 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DAO, DRD1 |
2.52213 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, HMGCR, NR1H4, PPARA, PTPN1, THRA, THRB, TNKS, TNKS2, XDH |
2.50772 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, CYP1B1, CYP3A4, FDPS, HMGCR, PTAFR |
2.50762 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.49042 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, HMGCR, PTAFR, XDH |
2.4871 |
[BP] GO:0007617 |
None
|
DRD1, THRA, THRB |
2.43155 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, GRM1, PTAFR, SLC1A1, THRA, THRB |
2.43013 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ADRA2C, BCL2, CA2, CA7, CYP19A1, DRD1, GRIK5, GRM5, HMGCR, NR1H4, PPARA, PTAFR, PTPN1, THRA |
2.43013 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AOX1, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, ESR1, ESR2, ESRRA, ESRRB, FDPS, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NR1H4, PPARA, THRA, THRB, TYR, XDH |
2.43013 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.43013 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.43013 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.43013 |
[BP] GO:0006808 |
regulation of nitrogen utilization
|
BCL2, NR1H4 |
2.43013 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD1, FABP3, GRIA2, GRIA4, GRIK5, NR1H4, PPARA, SLC1A1 |
2.4126 |
[BP] GO:0007268 |
None
|
DRD1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.4126 |
[BP] GO:0098916 |
None
|
DRD1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.4126 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, GRIK5, GRM5, NR1H4, PTAFR |
2.4126 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA3, PTAFR |
2.41144 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, ESR1, FABP3, GRM1, GRM5, NR1H4 |
2.38383 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, BCL2, CDC25B, CSNK2A1, DRD1, ESR1, F3, FABP4, GRM1, GRM3, GRM5, HMGCR, PTAFR, PTPN1, TNKS, XDH |
2.38303 |
[BP] GO:0099536 |
None
|
DRD1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.36353 |
[BP] GO:0099537 |
None
|
DRD1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.36353 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.35825 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CSNK2A1, CYP1B1, F3, GRM1, HMGCR, NR1H4, PTPN1, TNKS, TNKS2, XDH |
2.33547 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FUT7, GBA2, HMGCR, HSD17B1, HSD17B2, NR1H4, PPARA, PTAFR, PTPN1, THRA, THRB, TNKS, TNKS2, TYR, XDH |
2.33523 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, HMGCR, PTAFR |
2.33147 |
[BP] GO:0046888 |
None
|
ADORA1, ADRA2A, ADRA2C, HMGCR |
2.2961 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA2C, DRD1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.26031 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.26031 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26031 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA2A, ADRA2C, PTAFR |
2.2594 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FABP4, FUT7, GBA2, XDH |
2.23147 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, BCL2, CA1, CSNK2A1, F3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, NR1H4, PTAFR, PTPN1, TNKS, TNKS2 |
2.22021 |
[BP] GO:0008299 |
None
|
CYP1A1, FDPS, HMGCR |
2.2176 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.2176 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.2176 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.2176 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.2176 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.2176 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2176 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, GRM1, HMGCR, NR1H4, PTAFR, PTPN1, TNKS, TNKS2, XDH |
2.21523 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA2C, BCL2, DRD1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.20845 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, F3, FABP3, FABP4, GRIK5, GRM1, GRM5, HMGCR, HSD11B2, HSD17B2, NR1H4, PPARA, PTAFR, PTPN1, THRA, TYR |
2.20757 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.2001 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.2001 |
[BP] GO:0031644 |
None
|
ADORA1, ADRA2C, GRM1, PTAFR |
2.17981 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, BCL2, CA2, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, GRM1, HMGCR, NR1H4, PTAFR, SLC1A1, THRA, THRB, TNKS2, XDH |
2.17299 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, DRD1, NR1H4, TNKS, TNKS2 |
2.16872 |
[BP] GO:1900543 |
None
|
ADRA2A, GRM3, GRM8, PPARA |
2.16405 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.15854 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.15854 |
[BP] GO:0045980 |
None
|
ADRA2A, GRM3, GRM8, PPARA |
2.14643 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, FABP3, HMGCR, HSD11B2, PTAFR |
2.13665 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD1, ESRRB, GRM3, GRM8, PPARA |
2.09765 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, ADRA2C, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, ESR1, ESR2, F3, FABP4, GRM1, GRM3, GRM5, HMGCR, NR1H4, PPARA, PTAFR, PTPN1, TNKS, XDH |
2.07429 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA3, PTAFR |
2.07429 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.07429 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1 |
2.06866 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FABP4, FUT7, GBA2, XDH |
2.06051 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.05625 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.05625 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.05625 |
[BP] GO:0060509 |
None
|
THRA, THRB |
2.05625 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.05625 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD1, ESRRB, GRM3, GRM8, PPARA |
2.05482 |
[BP] GO:0019098 |
None
|
DRD1, THRA, THRB |
2.05119 |
[BP] GO:0007176 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.05119 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.01015 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.01015 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.49896 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, GBA2, GRIA2, HMGCR, HSD11B1, HSD11B2, HSD17B2 |
3.17404 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA2A, CA2, CA4, DRD1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC1A1 |
2.93987 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALPL, BCL2, CA12, CA14, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, ESR1, F3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTAFR, PTPN1, SLC1A1, TNKS, TNKS2, TYR |
2.43678 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.43013 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, GBA2, GRIA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTPN1 |
2.43013 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, ADRA2C, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.26658 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALPL, BCL2, CA12, CA14, CA2, CA4, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, ESR1, F3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTAFR, PTPN1, SLC1A1, TYR |
2.26031 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, ADRA2C, CA4, DRD1, F3, GRIA2, GRM1, GRM3, GRM5, GRM8, PTAFR, SLC1A1 |
2.00171 |
[MF] GO:0046914 |
transition metal ion binding
|
AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, PTPN1, THRA, THRB, TNKS, TYR, XDH |
9.80381 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.33933 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, THRA, THRB |
8.33933 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, THRA, THRB |
8.33933 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.17591 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, THRA, THRB |
7.78278 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, NR1H4, PPARA, PTAFR, THRA, THRB |
7.24053 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, CDK6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, NR1H4, PPARA, PTAFR, THRA, THRB |
6.92374 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, NR1H4 |
6.65331 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
6.50199 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
6.47029 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, NR1H4, PPARA, PTAFR, THRA, THRB |
6.47029 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, NR1H4, PPARA, PTAFR, THRA, THRB |
5.73577 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.30911 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.05008 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, PTPN1, THRA, THRB, TNKS |
5.05008 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.01916 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, HMGCR, HSD17B1, NR1H4, PPARA, PTAFR, PTPN1, SLC1A1, THRA, THRB, TNKS, TNKS2, TYR, XDH |
4.50249 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.48429 |
[MF] GO:0008289 |
lipid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, NR1H4, PPARA, PTAFR |
4.40968 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.39188 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, HMGCR, HSD11B2, HSD17B1, XDH |
4.16268 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.09873 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.86931 |
[MF] GO:0005506 |
iron ion binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
3.79091 |
[MF] GO:0004887 |
None
|
NR1H4, THRA, THRB |
3.6187 |
[MF] GO:0030594 |
None
|
DRD1, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
3.59951 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.49021 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, ESR1, ESR2, ESRRA, ESRRB, FDPS, NR1H4, PPARA, PTPN1, SLC1A1, THRA, THRB, TNKS, TNKS2, TYR, XDH |
3.47702 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.37534 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.29323 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, F3, FDPS, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTPN1, TNKS, TNKS2, TYR, XDH |
2.9464 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
2.86976 |
[MF] GO:0046872 |
metal ion binding
|
ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, FDPS, NR1H4, PPARA, PTPN1, SLC1A1, THRA, THRB, TNKS, TNKS2, TYR, XDH |
2.86343 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.81352 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.81352 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.79134 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, DRD1, F3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTAFR |
2.52836 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, DRD1, F3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTAFR |
2.52836 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.5159 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.50762 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.43155 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.43155 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.43013 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.43013 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.43013 |
[MF] GO:1901338 |
None
|
ADRA2A, ADRA2C, DRD1 |
2.41144 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.26502 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.2176 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.2176 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.2176 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.2176 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.2176 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA3, PTAFR |
2.19612 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.17271 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.07429 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.05625 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.05625 |